A/Prof. Silva Zavarsek

Healthcare Funding Decisions and Real-World Benefits: Reducing Bias by Matching Untreated Patients

P Ghijben, D Petrie, S Zavarsek, G Chen, E Lancsar

(2021), Vol. 39, pp. 741-756, PharmacoEconomics, New Zealand, C1

Rationale and design of the intravenous iron for treatment of anemia before cardiac surgery trial

P Myles, T Richards, A Klein, J Smith, E Wood, S Heritier, D McGiffin, S Zavarsek, J Symons, Z McQuilten, R Baker, K Karkouti, S Wallace

(2021), Vol. 239, pp. 64-72, American heart journal, Amsterdam, The Netherlands, C1

Revealed and stated preferences of decision makers for priority setting in health technology assessment: a systematic review

P Ghijben, Y Gu, E Lancsar, S Zavarsek

(2018), Vol. 36, pp. 323-340, PharmacoEconomics, New York, N.Y., C1

6-PACK programme to decrease fall injuries in acute hospitals: Cluster randomised controlled trial

A Barker, R Morello, R Wolfe, C Brand, T Haines, K Hill, S Brauer, M Botti, R Cumming, P Livingston, C Sherrington, S Zavarsek, R Lindley, J Kamar

(2016), Vol. 352, BMJ (Online), England, C1

The extra resource burden of in-hospital falls: a cost of falls study

R Morello, A Barker, J Watts, T Haines, S Zavarsek, K Hill, C Brand, C Sherrington, R Wolfe, M Bohensky, J Stoelwinder

(2015), Vol. 203, pp. 367-375, Medical journal of Australia, Sydney, N.S.W., C1

Preferences for oral anticoagulants in atrial fibrillation: a best-best discrete choice experiment

P Ghijben, E Lancsar, S Zavarsek

(2014), Vol. 32, pp. 1115-1127, Pharmacoeconomics, Berlin, Germany, C1-1

In-hospital falls and fall-related injuries: a protocol for a cost of fall study

R Morello, A Barker, T Haines, S Zavarsek, J Watts, K Hill, C Brand, C Sherrington, R Wolfe, M Bohensky, J Stoelwinder

(2013), Vol. 19, pp. 1-6, Injury prevention, London, England, C1-1

Evaluating the impact of depression, anxiety & autonomic function on health related quality of life, vocational functioning and health care utilisation in acute coronary syndrome patients: the ADVENT study protocol

J Oldroyd, S Cyril, B Wijayatilaka, A O'Neil, D McKenzie, S Zavarsek, K Sanderson, D Hare, A Fisher, A Forbes, C Barr Taylor, D Clarke, I Meredith, B Oldenburg

(2013), Vol. 13, pp. 1-9, BMC cardiovascular disorders, London, Eng., C1-1

Genotypic antiretroviral resistance testing at viral failure in people with HIV

S Zavarsek, O Abdulwadud

(2013), Vol. 2013, Cochrane Database of Systematic Reviews, Chichester, Eng., C1-1

The 6-PACK programme to decrease falls and fall-related injuries in acute hospitals : protocol for an economic evaluation alongside a cluster randomised controlled trial

R Morello, A Barker, S Zavarsek, J Watts, T Haines, K Hill, C Sherrington, C Brand, D Jolley, J Stoelwinder

(2012), Vol. 18, pp. 1-6, Injury prevention, London, England, C1-1

The 6-PACK programme to decrease fall-related injuries in acute hospitals: protocol for a cluster randomised controlled trial

A Barker, C Brand, T Haines, K Hill, S Brauer, D Jolley, M Botti, R Cumming, P Livingston, C Sherrington, S Zavarsek, R Morello, J Kamar

(2011), Vol. 17, pp. 1-6, Injury prevention, London, England, C1

Elf5 is essential for early embryogenesis and mammary gland development during pregnancy and lactation

Jiong Zhou, Renee Chehab, Josephine Tkalcevic, Matthew Naylor, Jessica Harris, Trevor Wilson, Sue Tsao, Irene Tellis, Silva Zavarsek, Dakang Xu, Erika Lapinskas, Jane Visvader, Geoffrey Lindeman, Ross Thomas, Christopher Ormandy, Paul Hertzog, Ismail Kola, Melanie Pritchard

(2005), Vol. 24, pp. 635-644, EMBO journal, Heidelberg, Germany, C1-1

Evaluating heterogeneity in cumulative meta-analyses

Elmer Villanueva, Silva Zavarsek

(2004), Vol. 4, pp. 1-8, BMC medical research methodology, London, Eng., C1-1

The chromosome 21 transcription factor ETS2 transactivates the β-APP promoter: implications for Down syndrome

E Wolvetang, O Bradfield, M Tymms, S Zavarsek, T Hatzistavrou, I Kola, P Hertzog

(2003), Vol. 1628, pp. 105-110, Biochimica et Biophysica Acta (BBA) - gene structure and expression, Amsterdam, The Netherlands, C1-1

Gene targeting of Desrt, a novel ARID class DNA-binding protein, causes growth retardation and abnormal development of reproductive organs

M Lahoud, S Ristevski, D Venter, L Jermiin, I Bertoncello, S Zavarsek, S Hasthorpe, J Drago, D de Kretser, P Hertzog, I Kola

(2001), Vol. 11, pp. 1327-1334, Genome research, Cold Spring Harbor, N.Y., C1-1

Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization

M Gowen, F Lazner, R Dodds, R Kapadia, J Feild, M Tavaria, I Bertoncello, F Drake, S Zavarsek, I Tellis, P Hertzog, C Debouck, I Kola

(1999), Vol. 14, pp. 1654-1663, Journal of bone and mineral research, Chichester, Eng., C1-1